Nuformix (FRA:1RT) Accounts Payable: €0.26 Mil (As of Mar. 2026)


What is Nuformix Accounts Payable?

Nuformix FRA:1RT +200.00% Accounts Payable is €0.26 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Nuformix's Accounts Payable for the quarter that ended in Mar. 2026 was €0.26 Mil.

Nuformix's quarterly Accounts Payable declined from Mar. 2025 (€0.28 Mil) to Sep. 2025 (€0.05 Mil) but then increased from Sep. 2025 (€0.05 Mil) to Mar. 2026 (€0.26 Mil).

Nuformix's annual Accounts Payable declined from Mar. 2023 (€0.31 Mil) to Sep. 2024 (€0.04 Mil) but then increased from Sep. 2024 (€0.04 Mil) to Sep. 2025 (€0.05 Mil).

Nuformix Accounts Payable Historical Data

* Premium members only.

The historical data trend for Nuformix's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix Accounts Payable Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24 Sep25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.01 0.31 0.04 0.05

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.04 0.28 0.05 0.26

Nuformix Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.26 Mil mean?
Nuformix (FRA:1RT) has a Accounts Payable of €0.26 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Nuformix and its competitors.
Is Nuformix's Accounts Payable too high?
Nuformix's current Accounts Payable is €0.26 Mil.
How does Nuformix's Accounts Payable compare to VRTX and REGN?
Nuformix's Accounts Payable of €0.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Nuformix and its competitors. Nuformix's current Accounts Payable is €0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuformix stock overvalued right now?
Nuformix (FRA:1RT) has a current Accounts Payable of €0.26 Mil. The current Accounts Payable is €0.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Nuformix (FRA:1RT), the current Accounts Payable is €0.26 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuformix Business Description

Other Exchanges NFX:UK1RT:Germany
Address C/O Arch Law Limited, 8 Bishopsgate, Huckletree Bishopsgate, London, GBR, EC2N 4BQ
Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.